National Cancer Institute's evaluation of unconventional cancer treatments.
Hawkins
M J
MJ
Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Md 20892.
Friedman
M A
MA
D002985:Clinical Protocols; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000628:therapy*; D014481:United States
D006834:Hydrazines; C029424:hydrazine